Pliant Therapeutics
Eric Giguere is an experienced quality assurance professional with a strong background in the biotechnology and pharmaceuticals industries. Currently serving as Vice President of Quality at Pliant Therapeutics, Eric has held key leadership roles at various companies, including Head of Global Audit and Compliance at FUJIFILM Diosynth Biotechnologies and Executive Director/Quality Site Head at Taysha Gene Therapies, where responsibilities included the development of quality systems to support clinical development and regulatory approval. Prior positions include Quality Site Head and Director of Quality Assurance at bluebird bio, Sr Manager of Quality Assurance Validation at Cubist Pharmaceuticals, and Associate Director of Validation at Shire HGT. Eric Giguere began their career as a Validation Engineer at ValSource and has a Bachelor of Science degree in Biology from Salve Regina University.
This person is not in any offices
Pliant Therapeutics
Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.